Massive data study checks if diabetes drug protects hearts
NCT ID NCT06659744
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study analyzed health records from over 158,000 people with type 2 diabetes to see if injectable semaglutide reduces major heart problems like heart attacks and strokes. Researchers used real-world data to mimic a previous clinical trial, aiming to learn when such data can be trusted. The study did not involve new treatments or direct patient contact.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02120, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Kidney clues may predict eye swelling after cataract surgery in diabetes patients
- AI-Powered trial asks: does adding a second drug cut heart failure risk?
- Scientists hunt for hidden fat molecules that sabotage insulin
- Can a pharmacist check-in boost medication adherence in diabetes and kidney disease?
- New oral diabetes drug shows promise in early safety trial
- Could a simple breathing exercise ease pain and anxiety during nerve testing?